Back to Search Start Over

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

Source :
Financial Services Monitor Worldwide. December 27, 2023
Publication Year :
2023

Abstract

(GlobeNewswire) - Dar Bioscience, Inc. (NASDAQ: DARE), a leader in womens health innovation, today announced it has entered into a royalty-backed financing agreement that provides Dar with $5 million at [...]

Subjects

Subjects :
Rate of return
Biotechnology industry -- Licensing agreements
Governmental investigations
Return on investment
Company licensing agreement
Banking, finance and accounting industries

Details

Language :
English
Database :
Gale General OneFile
Journal :
Financial Services Monitor Worldwide
Publication Type :
News
Accession number :
edsgcl.778448542

Tools

Authors Abstract Subjects Details